- Optimi Health (CSE:OPTI) has made its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University
- The company obtained an export permit that is required from Health Canada to ship its in-house manufactured MDMA active pharmaceutical ingredient to the university in Israel
- The two entities first revealed their collaboration back in March, with the company’s product supporting the institution’s study on the impact of MDMA on alcohol addiction
- Shares of Optimi Health were unchanged at C$0.38 as of 11:39 am ET Thursday
Optimi Health (CSE:OPTI) revealed it has made its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University.
The company stated in a news release it obtained an export permit that is required from Health Canada to ship its in-house manufactured MDMA active pharmaceutical ingredient (APIR) to the university in Israel.
The permit also means Optimi Health is one of the first psychedelics’ pharmaceutical companies to ship MDMA to the country.
The two entities first revealed their collaboration back in March, with the company’s product supporting the institution’s study on the impact of MDMA on alcohol addiction.
“Partnering with IPR-TLV and shipping MDMA to Israel marks a significant advancement for Optimi,” Bill Ciprick, CEO of Optimi Health, said in a statement. “As a supplier with the ability to produce GMP psychedelic pharmaceuticals on demand, we are proud to be furthering our mission of supporting psychedelic research and innovation on a global scale.”
The company’s MDMA ingredient is fully synthesized in-house at its 10,000 square foot cultivation and formulation facility in Princeton, British Columbia. The materials used to formulate the product were also obtained through Optimi Health’s Health Canada Precursor License.
Optimi Health is a Health Canada-licensed psychedelics pharmaceutical manufacturer focused on controlled substances such as botanical psilocybin and MDMA and functional mushrooms that focus on the health and wellness markets.
Shares of Optimi Health Corp. (CSE:OPTI) were unchanged at C$0.38 as of 11:39 am ET Thursday.
Join the discussion: Find out what everybody’s saying about this stock on the Optimi Health Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.